| Market Cap | ₹831Cr |
| ROE | 10.92% |
| P/E Ratio(TTM) | 21.64 |
| EPS(TTM) | 32.60 |
| P/B Ratio | 3.25 |
| Dividend Yield | 0.11% |
| Industry P/E | 31.82 |
| Book Value | 217.13 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Managing Director | Swapnil J. Shah |
| Founded | 2015 |
| NSE Symbol | REMUS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 98.96 | ||
| Anthem Biosciences | NA (0.00%) | 78.87 | ||
| Onesource Specialty Pharma | NA (0.00%) | 723.71 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 22.53 |